bioMérieux logo
Get more information
Product regulatory review varies by Country.
Not currently available for sale.

AmPORE-TB®
(For Research Use Only – Not for use in diagnostic procedures)

Analysis of genetic mutations thought to be associated with drug resistance in Mycobacterium tuberculosis complex (MTBC)
Designed by Oxford Nanopore Technologies*
Get more information

AmPORE-TB®

Characterize 24 resistance genes in Mycobacterium tuberculosis with an efficient next-generation DNA sequencing. As an exclusive distributor and support partner of Oxford Nanopore Technologies, bioMérieux brings to laboratories the complete solution including Oxford Nanopore sequencing device, reagents, and software for research use only.

ONT_3Line_Black_RGB.png

Tuberculosis is a Global Health crisis

“Accelerated efforts to diagnose TB and drug-resistance are essential to end the global TB epidemic.”

-WHO Global Tuberculosis Programme


About 10 million people contract tuberculosis every year. Although preventable and treatable, WHO considers tuberculosis world’s leading cause of death from a single infectious agent. Antimicrobial resistant-TB affects about 400,000 people annually and is especially deadly. Rapid, reliable antimicrobial susceptibility tests in Mycobacterium tuberculosis are needed to support effective treatment and curb the spread of resistance, especially in low- and middle-income countries, where 99% of new cases occur. 1,2

Contact US

Get More Information

Fill out the form below for more information or to be contacted by your local bioMérieux representative